CVE-2008-1386

Public Exploit

Description

Multiple cross-site scripting (XSS) vulnerabilities in the installer in Serendipity (S9Y) 1.3 allow remote attackers to inject arbitrary web script or HTML via (1) unspecified path fields or (2) the database host field. NOTE: the timing window for exploitation of this issue might be limited.

Category

4.3
CVSS
Severity: Medium
CVSS 2.0 •
EPSS 0.50%
Affected: n/a n/a
Published at:
Updated at:

References

Link Tags
http://archives.neohapsis.com/archives/fulldisclosure/2008-04/0590.html mailing list
http://www.securityfocus.com/archive/1/491176/100/0/threaded mailing list
http://www.securityfocus.com/bid/28885 exploit vdb entry patch
http://www.vupen.com/english/advisories/2008/1348/references vdb entry
http://int21.de/cve/CVE-2008-1386-s9y.html
http://www.securitytracker.com/id?1019915 vdb entry
https://exchange.xforce.ibmcloud.com/vulnerabilities/41967 vdb entry
http://blog.s9y.org/archives/193-Serendipity-1.3.1-released.html

Frequently Asked Questions

What is the severity of CVE-2008-1386?
CVE-2008-1386 has been scored as a medium severity vulnerability.
How to fix CVE-2008-1386?
To fix CVE-2008-1386, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2008-1386 being actively exploited in the wild?
It is possible that CVE-2008-1386 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.